Recommended Treatment for H. pylori Infection
The recommended first-line treatment for H. pylori infection is a 14-day regimen of either bismuth quadruple therapy or standard triple therapy, depending on local clarithromycin resistance patterns. 1
First-Line Treatment Options
In Areas with High Clarithromycin Resistance (≥15%)
Bismuth Quadruple Therapy (14 days) 1
- Proton pump inhibitor (PPI) twice daily
- Bismuth 300mg four times daily
- Tetracycline 500mg four times daily
- Metronidazole 500mg three times daily
- Eradication rate: approximately 85%
Concomitant Non-Bismuth Quadruple Therapy (14 days) 1, 2
- PPI twice daily
- Amoxicillin 1g twice daily
- Metronidazole 500mg three times daily
- Clarithromycin 500mg twice daily
- Eradication rate: approximately 80%
In Areas with Low Clarithromycin Resistance (<15%)
Standard Triple Therapy (14 days) 1, 3
- PPI twice daily
- Amoxicillin 1g twice daily
- Clarithromycin 500mg twice daily
- Eradication rate: approximately 85%
For Penicillin Allergy 1
- Use bismuth quadruple therapy as described above
Second-Line Treatment Options
If first-line treatment fails, consider:
Levofloxacin-Based Regimen (14 days) 1, 4
- PPI twice daily
- Bismuth 300mg four times daily
- Levofloxacin 500mg once daily
- Tetracycline 500mg four times daily
Special Considerations
H. pylori Eradication for Duodenal Ulcer Disease
- Triple therapy: 1 gram amoxicillin, 500 mg clarithromycin, and 30 mg lansoprazole, all given twice daily for 14 days 3
- Dual therapy: 1 gram amoxicillin and 30 mg lansoprazole, each given three times daily for 14 days 3
Dosage Adjustment for Renal Impairment
- For GFR 10-30 mL/min: Amoxicillin 500mg or 250mg every 12 hours 1, 3
- For GFR <10 mL/min: Amoxicillin 500mg or 250mg every 24 hours 3
Treatment Duration
- 14-day regimens are superior to 7-day regimens, providing approximately 5% better eradication rates 1, 4
- High-dose PPI increases the efficacy of triple therapy by 6-10% compared to standard doses 1
Confirmation of Eradication
- Confirm eradication at least 4 weeks after completion of treatment 1
- Use urea breath test (UBT) or laboratory-based validated monoclonal stool antigen test 1
- Ensure patient has been off PPI for at least 2 weeks before testing 1
Patient Education
- Take medications with meals to improve tolerance and efficacy 1
- Complete the full course of treatment to ensure successful eradication 1
- Be aware of potential side effects:
- Darkening of stool (bismuth)
- Metallic taste
- Nausea and diarrhea
- Skin rash
- Muscle and joint pains 1
Common Pitfalls to Avoid
Using clarithromycin-based regimens in areas with high resistance - In areas with clarithromycin resistance >15-20%, avoid clarithromycin-based regimens 1, 2
Insufficient treatment duration - 7-day regimens have lower eradication rates; 14-day regimens are now strongly recommended 1, 4
Failure to confirm eradication - Always confirm eradication to ensure treatment success 1
Inadequate acid suppression - Use high-dose PPI to increase efficacy 1
Not considering previous treatment history - Previous treatments significantly affect eradication success rates 5